NFKB1 and colorectal carcinoma: In this current report, activin's pro-oncogenic actions appear to be not only mediated by NFkB as one of many effectors, but unexpectedly NFkB appears to be central to the detrimental aspects of activin signaling in CRC leading to cellular proliferation in the context of SMAD4-independent signaling.